It is the cache of ${baseHref}. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Journal of Chinese Integrative Medicine Free Full Text
 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Thursday, March 06, 2014
 How to Show Chinese in English Operating System
Original Clinical Research
Journal of Chinese Integrative Medicine: Volume 7   July, 2009   Number 7

DOI: 10.3736/jcim20090706
Serum proteomes of hypertension patients with abundant phlegm-dampness
1. Yu-guang CHU (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
2. Jie SHI (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
3. Yuan-hui HU (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China E-mail: huiyuhui@yahoo.com.cn)
4. Hua-qin WU (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
5. Gui-jian LIU (Clinical Laboratory, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
6. Chao-jun HU (Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China )
7. Yong-zhe LI (Clinical Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China )
8. Yi LI (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
9. Zi-jing CHEN (Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
10. Qing HE (Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China )
Objective: To study the serum proteomes of essential hypertension (EH) patients with abundant phlegm-dampness, and try to find special proteins associated with abundant phlegm-dampness syndrome.
Methods: Fifty-nine hypertension patients were included, and the patients were divided into abundant phlegm-dampness syndrome group (39 cases) and non-phlegm-dampness syndrome group (20 cases). To find the special proteins associated with abundant phlegm-dampness, the EH patients with non-phlegm-dampness and another 30 healthy persons were regarded as control. Weak cation nano-magnetic beads were used to capture proteins in serum, and proteomic fingerprint was made by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). All the proteomic fingerprints were analyzed by Biomarker Wizard 3.1 Software. Then Biomarker Patterns Software (BPS) 5.0 was used to identify the differentiated proteins, which could induce phlegm-dampness.
Results: There were 102 differentiated protein peaks between abundant phlegm-dampness and the control group. The best markers of abundant phlegm-dampness were protein peaks with the mass to charge ratio (m/z) of 9 334.958 m/z (the expression increased), 9 280.191 m/z (the expression decreased), 8 030.794 m/z (the expression increased), and 2 941.551 m/z (the expression increased). These four protein peaks found by BPS could induce abundant phlegm-dampness. They could be used to separate the abundant phlegm-dampness syndrome from the healthy persons and the hypertension patients with non-phlegm-dampness. The sensitivity of the model was 93.103% (27/29), specificity was 92% (23/25), false positive rate was 8% (2/25), false negative rate was 6.897% (2/29) and Youden's index was 85.103%. Blind test data indicated a sensitivity of 90% (9/10) and a specificity of 88% (22/25), and the false positive rate was 12% (3/25), false negative rate was 10% (1/10), and Youden's index was 78%.
Conclusion: The differentiated proteins between the abundant phlegm-dampness group and the control group are the material foundation of abundant phlegm-dampness. The selected differentiated proteins can be used to distinguish the EH patients with abundant phlegm-dampness from the healthy persons and the EH patients with non-phlegm-dampness. The molecular biology diagnosis model can offer an objective and accurate way for TCM syndrome differentiation.
JCIM
Open Access
THIS ARTICLE
-  Abstract
-  Full text
-  Download PDF file
-  Send to a friend
-  Related articles in JCIM
-  Cited in JCIM
-  Reader's comments
-  Send a comment

Chu YG, Shi J, Hu YH, Wu HQ, Liu GJ, Hu CJ, Li YZ, Li Y, Chen ZJ, He Q. J Chin Integr Med. 2009; 7(7): 629-635. Received February 14, 2009; accepted April 14, 2009; published online July 15, 2009. Indexed/abstracted in and full text link-out at PubMed. Journal title in PubMed: Zhong Xi Yi Jie He Xue Bao. Free full text (HTML and PDF) is available at www.jcimjournal.com. Forward linking and reference linking via CrossRef. DOI: 10.3736/jcim20090706

 

Correspondence: Prof. Yuan-hui HU; Tel: 010-88001018; E-mail: huiyuhui@yahoo.com.cn

 

Jump to Section
-   Top
-   Article & Author Info
-   Introduction
-   Clinical data and methods
-   Results
-   Discussion
-   References
   

    The core of traditional Chinese medicine (TCM) is syndrome differentiation treatment, and syndrome is a pathological manifestation with a certain regulation. By observing the patient's abnormal manifestation, one can grasp the nature of the disease. External pathological manifestation is bound to its material basis, which can be explained by proteomics study. After the study of proteomics relating to TCM syndrome of essential hypertension (EH) patients, the basis of the proteomics resulting from TCM syndrome of the EH patients was researched, and the syndrome-protein expression profiling was established to reveal the scientific meanings of TCM syndrome, and to further supply the basis and methods of the objectiveness of TCM syndrome differentiation.

 
   

1   Clinical data and methods
1.1   Clinical data
1.1.1   Study objects 
  From June to November 2008, 52 EH patients in Department of Cardiology, Guang'anmen Hospital, including 39 EH patients with abundant phlegm-dampness and 20 EH patients with non-abundant phlegm-dampness were included in the study, and another 30 healthy persons were also included.
1.1.2   Diagnostic criteria   The diagnosis of hypertension followed A Draft of Chinese Guidelines for Hypertension Prevention and Treatment
1. The diagnosis of TCM syndrome followed National Standards of People’s Republic of China: Syndrome Part of Terminology of Traditional Chinese Medicine Clinical Diagnosis and Treatment2 and Guidelines for Clinical Research on Chinese New Herbal Medicines3. The main common symptoms of abundant phlegm-dampness syndrome including sticky sputum, sputum expectoratant, limb heaviness, stuffiness and oppression in chest and epigastrium, poor appetite, greasy taste in the mouth, white and greasy tongue coating, moderate and soggy pulse or slippery pulse. Patients meeting the hypertension diagnosis filled TCM syndrome scale, and then two associate chief physicians performed the syndrome differentiation according to the TCM scale.
1.1.3   Including criteria   The patients who met with the diagnostic criteria were included, and they were asked to fill the TCM scale. The blood biochemical tests including blood glucose, blood lipid, liver and kidney function, and uric acid, and the necessary clinical examinations including electrocardiogram, ambulatory blood pressure, and carotid artery ultrasound were performed.
1.1.4   Excluding criteria   1) Patients with chronic diseases such as secondary hypertension, hyperlipidemia, diabetes, cerebral infarction, cerebral hemorrhage, angina pectoris, myocardial infarction, abnormal lipid metabolism and atherosclerosis diagnosed by carotid artery ultrasound; 2) Patients with cancer history; 3) Patients with liver and kidney dysfunction, hypothyroidism, hypoproteinemia, alcoholism and mental diseases.
1.2   Study methods
1.2.1   Materials and instruments 
  Weak cation-exchange (WCX) nano-magnetic beads were from SELDI Bio-engineering Technology Co., Ltd., Beijing. Tris (hydroxymethyl) aminomethane (Tris), 3-cyclohexylamino-1-propanesulfonic acid (CHA-PS), acetonitrile (ACN), dithiothreitol (DTT), and sinapic acid (SPA) were purchased from Sigma Co., Ltd. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) PBS-Ⅱc protein chip reader (Ciphergen Inc., USA), Hitachi-SCR20BA high-speed refrigerated centrifuge (Hitachi Co., Ltd., Japan), and Sanyo-MDF-U73V Ultra-low temperature refrigerator (Sanyo Electric, Japan).
1.2.2   Methods of obtaining and processing samples   Three milliliters of fasting blood were collected in the morning, contained in BD vacuum test tube without anticoagulant, stored for 1 hour at 4 ℃, and centrifuged at the speed of 3 000 r/min for 10 minutes, and then the blood serum was split into 5 tubes, each tube 100 μL and stored in
86 ℃ refrigerator. For analysis, took the serum out from refrigerator, melt the serum with ice-bath and then centrifuged for 10 minutes with 2 000×g at 4 ℃. The serum (10 μL) was taken and added to 20 μL U9 buffer solution (9 mol/L urea, 20 g/L CHAPS, 10 g/L DTT, 50 mmol/L Tris-HCl, pH 9.0), well mixed, till centrifuged for 30 minutes at 4 ℃, and 100 mmol/L NaAc 370 μL (pH 4.0) was added and mixed immediately.
1.2.3   Activation of weak cation-exchange nano-magnetic beads   WCX nano-magnetic beads (10 g/L, 50 μL) was added to each PCR tube, and separated for 2 minutes on the magnetic separation plate. The supernatant part was discarded, and then 100 mmol/L NaAc 100 μL was added for activating two times, 5 minutes each time.
1.2.4   Serum protein captured by activated nano-magnetic beads   A total of 100 μL prepared serum sample was added into the activated magnetic beads, and then oscillated and incubated for 1 hour. After two-minute separation on the magnetic separation plate, the supernatant part was discarded and 100 mmol/L NaAc 100 μL was added and eluted for 2 times, 5 minutes each time. The protein was eluted and combined with the magnetic beads for 5 minutes by 5 mL/L trifluoroacetic acid (TFA) 10 μL. The protein eluent (5 μL)was mixed with 5 μL saturated SPA, and then absorbed 2 μL protein mixture spotting on the Au-chip (just as vector effect; Au-chip, Ciphergen Biosystems Inc.), dried naturally, and the protein fingerprint was detected by PBS-Ⅱc protein chip reader.
1.2.5   Chip detection   The parameters of chip reading instrument were set to the maximum detection range of 5 000, optimized scope of 2 000
-10 000, laser intensity of 205, and detection sensitivity of 8. Before testing, adjusted the instrument using all-in-one polypeptide standard chip, and system quality deviation was less than or equal to 0.1%. The original data were processed by ProteinChip Software 3.1 in standardization and protein peak of 4 091 m/z (mass to charge ratio) was used as internal standard to correct.
1.2.6
   Establishment and verification of model   Linear classification analysis was made to the peaks of differentially expressed proteins with same relative molecular masses between the abundant phlegm-dampness group and the control groups (EH patients with non-phlegm-dampness and healthy persons) by Biomarker Pattern software (BPS). With further optimization of the experiment para-meters, we determined the best classification model and output original results, and then carried out cross-validation and exported the results by BPS. The model is based on the neural network decision tree, and a best training sample was determined first. The choice of computing equation is the default choice of classification, if no logistic regression would be chosen, and the core operational idea is Bayes criteria. Classification function was used to classify and the higher score Yi function belongs to i kinds. The core operational idea of independent variable was applied for all possible set method in multiple regressions after t test. The neural network decision tree was used for drawing the decision tree after the determination of types and equation. All results were automatically formed by BPS software.
1.2.7
   Perspective evaluation   Blind test (perspective evaluation) was performed to establish abundant phlegm-dampness model by testing the protein fingerprint and the sensitivity, specificity, false positive rate, false negative rate as well as Youden's index of the model for abundant phlegm-dampness were obtained.
1.3
   Statistical analysis   Statistical treatment of the protein fingerprint was performed by using Ciphergen ProteinChip software and BioMarker Wizard software. T-test was applied for the contrast between the abundant phlegm-dampness group and the control group (selected together, operated respectively and then summed up) with the data expressed as `x±s and α=0.05 as statistical standard. After the mass spectrogram of differential protein peak was formed, BPS 5.0 was used to identify and diagnose the best marker of abundant phlegm-dampness and establish the diagnostic model of abundant phlegm-dampness. SPSS was used to perform Chi-Square and ANOVA analysis for the general information (gender, age) of the objects.

Jump to Section
-   Top
-   Article & Author Info
-   Introduction
-   Clinical data and methods
-   Results
-   Discussion
-   References
   

2   Results
2.1   Baseline data 
  There was no significant difference in general information between the abundant phlegm-dampness group and the control group (P>0.05). Detailed information and clinical grouping are listed in Table 1. To find out the special protein in the EH patients with abundant phlegm-dampness, the EH patients with non-phlegm-dampness and another group of healthy persons were combined as the control.
2.2   Fingerprint of proteins and the establishment of abundant phlegm-dampness model   A total of 102 significantly differentiated protein peaks were tested in the abundant phlegm-dampness group and the control group (2 000
-5 000 m/z), among which 20 kinds of proteins were higher in the abundant phlegm-dampness group than in the control group, while the other 82 kinds of proteins were lower in the abundand-dampness group than in the control group (P<0.05). The information was shown in Table 2.
    

Table 1   Clinical data and packet information

Group

n

Male/Female
(Cases)

Age (Years)

Average age
(`x±s, years)

Modeling (Cases)

Blind text (Cases)

Normal

30

15/15

20-56

49.91±10.26

15

15

Non-abundant phlegm-dampness

20

21/18

16-59

52.35±11.22

10

10

Abundant phlegm-dampness

39

11/9

19-59

50.68±10.05

29

10

    

Table 2   Differentiated protein peaks

m/z

m/z

m/z

m/z

m/z

m/z

m/z

m/z

2 006.818*

3 887.151*

4 497.380

5 214.152

5 807.037

6 829.344

7 813.754

9 495.915

2 018.805*

3 936.318

4 533.016

5 246.498

5 846.632

6 846.526

7 828.585

10 179.280

2 238.140*

3 957.645

4 647.887

5 340.609*

6 198.601

6 969.257

8 030.794*

11 078.130*

2 546.051

3 974.755

4 752.432

5 475.257*

6 298.461

7 000.946

8 277.397

11 369.050

2 761.555

3 989.617

4 763.711

5 519.908

6 311.630

7 052.607

8 337.660

11 478.980

2 871.509

4 071.080

4 791.812

5 539.739

6 355.350

7 080.104

8 599.531

12 096.720

2 941.551*

4 092.452

4 886.402*

5 555.771

6 379.086*

7 144.659*

8 819.858

12 543.330

3 089.231

4 155.501

4 963.829

5 586.006

6 426.604

7 206.562*

8 853.621

12 646.800

3 161.262

4 175.258

4 992.906

5 634.816

6 475.907

7 255.409

8 922.654

16 710.000

3 292.019

4 301.903*

5 023.282

5 701.429*

6 503.667

7 410.660

9 051.455

18 016.100

3 687.000

4 382.989*

5 063.736

5 730.362*

6 581.261

7 477.221

9 130.553

18 517.140*

3 817.091

4 442.688*

5 098.803

5 748.292

6 624.362

7 636.356

9 280.191

21 641.550

3 829.682

4 473.557

5 132.748

 

6 810.002

7 762.536

9 334.958*

 

*: These 20 kinds of proteins were higher in the abundant phlegm-dampness group than in the control group, and the other 82 kinds of proteins were lower in the abundant phlegm-dampness group than in the control group (P<0.05).

 

2.3   Best marker of abundant phlegm-dampness   Differential protein peaks obtained from abundant phlegm-dampness modeling group and control modeling group were analyzed by BPS software to select the best marker for diagnosis of abundant phlegm-dampness. The results showed that the best markers of abundant phlegm-dampness were protein peaks of 9 334.958 m/z (the expression increased), 9 280.191 m/z (the expression decreased), 8 030.794 m/z (the expression increased), and 2 941.551 m/z (the expression increased). The information was shown in Figure 1. The model formed by these four protein markers (Figure 2) can classify the EH patients with abundant phlegm-dampness clearly, and the sensitivity of the model was 93.103% (27/29), specificity was 92% (23/25), false positive rate was 8% (2/25), false negative rate was 6.897% (2/29) and Youden's index was 85.103%. Receiver operator characteristic (ROC) curve can be seen in Figure 3.


 

Figure 1   Mass spectrum of modeling protein peaks
The left stands for abundant phlegm-dampness group, and the right stands for control group.

 

Figure 2   Diagnostic decision tree model of abundant phlegm-dampness

 

Figure 3   ROC curve of diagnosis model of abundant phlegm-dampness

    
2.4   Blind test   Blind test was performed on establishing diagnostic model of abundant phlegm-dampness over 35 samples of protein fingerprint. The results showed that the sensitivity of the model was 90% (9/10), the specificity was 88% (22/25), false positive rate was 12% (3/25), false negative rate was 10% (1/10), and Youden's index was 78%.

Jump to Section
-   Top
-   Article & Author Info
-   Introduction
-   Clinical data and methods
-   Results
-   Discussion
-   References
   

3   Discussion
  
In recent years, with the rapid development of proteomics technology, proteomics study methods have been applied to clinical research
4, 5. A growing number of scholars carried out research on the nature of TCM syndrome by using the technology of proteomics. Xiao et al6 carried out the research for the serum protein in 23 hypertension cases of hyperactivity of liver yang syndrome, contrasted with the normal. A total of approximately 500 protein spots were detected, and there were 16 significantly differentiated proteins by group comparison. Then peptide mass fingerprinting (PMF) was made by using MALDI-TOF-MS. It was found that n-methyl-aspartyl acid receptor, serum ceruloplasmin, transferrin, vitamin D-binding protein, apolipoprotein were up-regulated in hyperactivity of liver yang group, and the expression of glucoprotein reduced. Xiong et al7 studied the serum protein differences between liver-yang transforming into wind and hyperactivity of liver-yang of hypertensive cerebral hemorrhage. Forty cases of hypertensive cerebral hemorrhage were divided into 17 cases of liver-yang transforming into wind and 23 cases of hyperactivity of liver-yang syndrome. The images were processed by using 2-DE electrophoresis, scanner and PDQuest V7.3.1 software, and the average protein points of serum map were 113 103 and 94 in liver-yang transforming into wind and hyperactivity of liver-yang syndrome of hypertensive cerebral hemorrhage as well as healthy persons respectively. Five proteins were preliminary identified, which were serum amyloid precursor, ceruloplasmin, vitamin D-binding protein, apo lipoprotein cⅢ and transfermin. These 5 proteins might be related to liver-yang transforming into wind syndrome of hypertensive cerebral hemorrhage.

   In this study of the serum proteomics in the hypertension patients with abundant phlegm-dampness, we found that there were 102 differential protein peaks between the abundant phlegm-dampness group and the control group (2 000-50 000 m/z), among which 20 kinds of proteins in the abundant phlegm-dampness group were higher than those in the control group, and the other 82 kinds of proteins in the abundant phlegm-dampness group were lower than those in the control group (P<0.05). The diagnostic model set up by four protein peaks of 9 334.958 m/z (the expression increased), 9 280.191 m/z (the expression decreased), 8 030.794 m/z (the expression increased), 2 941.551 m/z (the expression increased) could distinguish the hypertension patients with abundant phlegm-dampness syndrome from the hypertension patients with other TCM syndromes and normal. The sensitivity of the diagnostic model was 93.103%, specificity was 92%, false positive rate was 8%, and false negative rate was 6.897%. By blind test, the sensitivity was 90%, specificity was 88%, false positive rate was 12%, and false negative rate was 10%. The manifestation of TCM syndrome is based on the expression of specific protein. The molecular biology diagnostic model established by differentially expressed protein combined with artificial intelligence decision tree, had higher sensitivity and specificity, and provided the theoretical support and new syndrome differentiation method for TCM. 
   The discovery of specific protein provides the evidence for further study of the nature of TCM syndrome. The material basis of syndrome is the basis for correspondence of syndrome and treatment, and correspondence of prescription and syndrome.

Jump to Section
-   Top
-   Article & Author Info
-   Introduction
-   Clinical data and methods
-   Results
-   Discussion
-   References
   
References
1. Liu LS, Gong LS. A draft of Chinese guidelines for hypertension prevention and treatment[M]. Beijing: People's Medical Publishing House, 2005. Chinese.
2. State Bureau of Technical Supervision. National standards of People's Republic of China: Syndrome part of terminology of traditional Chinese medicine clinical diagnosis and treatment[M]. Beijing: Standards Press of China, 1997. Chinese.
3. Bureau of Drug Administration of China Ministry of Public Health. Guidelines for clinical research on Chinese new herbal medicines[M]. Beijing: Chinese Medical Science and Technology Press, 2002. Chinese.
4. Baumeister W. From proteomic inventory to architecture[J]. FEBS Lett, 2005, 579(4) : 933-937.
    
5. Chung CH, Levy S, Chaurand P, Carbone DP. Genomics and proteomics: emerging technologies in clinical cancer research[J]. Crit Rev Oncol Hematol, 2005, 61(1) : 1-25.
    
6. Xiao MF, Liang QH, Xiong XG, Zeng NJ, Ou JG, Zhang YX, Chen J, Liang XH, Zhao Y, Yang B, Fan R. Study of peripheral blood mononuclear cells of hypertension intracerebral hemorrhage patients with liver yang forming wind syndrome by proteomic method[J]. Shi Yong Yu Fang Yi Xue, 2008, 15(3) : 623-627. Chinese with abstract in English.
  
7. Xiong XG, Liang QH, Hou JL, Chen J, Liu AP, Yan DH, Guan YJ. Study on serum proteomes of hypertensive intracerebral hemorrhage patients with liver-yang forming wind syndrome and hyperactivity of liver-yang syndrome[J]. Shi Yong Yu Fang Yi Xue, 2007, 14(6) : 1649-1652. Chinese with abstract in English.
  
Jump to Section
-   Top
-   Article & Author Info
-   Introduction
-   Clinical data and methods
-   Results
-   Discussion
-   References
   
JCIM
Open Access
THIS ARTICLE
-  Abstract
-  Full text
-  Download PDF file
-  Send to a friend
-  Related articles in JCIM
-  Cited in JCIM
-  Reader's comments
-  Send a comment
    
Reader's comments
1. Holy coicsne data batman. Lol! (2011-6-26 0:00:00)
2. Holy coicsne data batman. Lol! (2011-6-26 0:00:00)
3. YQpraQ , [url=http://cxnwtamqhqst.com/]cxnwtamqhqst[/url], [link=http://dhcejelgpngq.com/]dhcejelgpngq[/link], http://otwlphoeojis.com/ (2011-6-27 0:00:00)
4. YQpraQ , [url=http://cxnwtamqhqst.com/]cxnwtamqhqst[/url], [link=http://dhcejelgpngq.com/]dhcejelgpngq[/link], http://otwlphoeojis.com/ (2011-6-27 0:00:00)
5. jO5P4a , [url=http://ssznsyuqdfsb.com/]ssznsyuqdfsb[/url], [link=http://sitmxgztccyk.com/]sitmxgztccyk[/link], http://owvawiqdduda.com/ (2011-6-29 0:00:00)
6. jO5P4a , [url=http://ssznsyuqdfsb.com/]ssznsyuqdfsb[/url], [link=http://sitmxgztccyk.com/]sitmxgztccyk[/link], http://owvawiqdduda.com/ (2011-6-29 0:00:00)

Send a comment

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977